Abnormal expression of CEBPB promotes the progression of renal cell carcinoma through regulating the generation of IL-6

BACKGROUND: The CCAAT/enhancer-binding protein beta (CEBPB), a transcription factor regulating immune and inflammatory responses, has been implicated in the pathogenesis of various malignancies. However, its specific regulatory mechanism in renal cell carcinoma (RCC) remains poorly understood. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yaoqiang, Guo, Wenke, Qiao, Baoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520310/
https://www.ncbi.nlm.nih.gov/pubmed/37767481
http://dx.doi.org/10.1016/j.heliyon.2023.e20175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520310/
https://www.ncbi.nlm.nih.gov/pubmed/37767481
http://dx.doi.org/10.1016/j.heliyon.2023.e20175

Ejemplares similares